TheStreet.com TV Recap: Vaccines Give Merck Booster Shot
Merck is (MRK Quote) winning big with vaccines, Jim Cramer said on TheStreet.com TV's Wall Street Confidential Web video Friday.
Cramer said the company decided to get into vaccines when everyone said there was no money in vaccines. That thinking turned out to be wrong. Becton Dickinson (BDX Quote) and Cepheid (CPHD Quote) also are doing well with vaccines, Cramer said. Gardasil, the human papillomavirus vaccine from Merck, is going to be huge, Cramer and stockpickr.com's James Altucher agreed. It's going from about $300 million to $4 billion in revenue over the next year, and that's just one vaccine, he said. Plus, now they're doing late-stage trials on a hepatitis-B vaccine. "I think if you want a solid 15%, maybe 20% a year for a long time, Merck is a great bet," Altucher said.Cramer & Altucher: Give Vaccines a Shot |
- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
-
Google Adds 'Buzz' to Gmail
The Wall Street Journal.
-
Ore Increases Boost Steel Prices
The Wall Street Journal.
-
Clive Palmer Clarifies His $60B China Coal Sale
Forbes.com: Business News
-
Why fret about Greece?
The Economist
-
Euro bounces back against dollar
BBC
-
China Passes Germany as Worlds Top Exporter
New York Times
-
IAC Posts Loss, but Still Beats Expectations
New York Times
-
Stiglitz Sees No Greek Default as ‘Speculative Attacks’ Persist
BusinessWeek Online
-
U.S. Stocks Rally on Growing Prospects for Bailout of Greece
BusinessWeek Online
-
Tuesday Reads
The Big Picture
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,058.64 | 1,070.52 | 2,150.87 | 36.33 |
Oil *
72.02
|
|
UP
150.25
|
UP
13.78
|
UP
24.82
|
UP
0.41
|
10 Yr
3.63%
SPDR Gold
105.45
|
|
+1.52%
|
+1.30%
|
+1.17%
|
+1.14%
|
Data delayed 20 minutes |
More From TheStreet
Latest HeadlinesBrokerage Partners
Sponsored Links














